Vickie Capps's Trading History
| OFIXOrthofix Medical | Jun 12, 2026 | Director | Uninformative Buy | ― | $392.73K | |
| JANXJanux Therapeutics Inc | Jun 12, 2026 | Director | Uninformative Buy | ― | $1.39M | |
| AMEDAmedisys | Aug 14, 2025 | ― | Uninformative Sell | ― | $0.00 | |
| OTICOtonomy | Nov 29, 2022 | ― | Informative Sell | 4.22K | $575.00 | |
| NUVANuVasive | Nov 10, 2020 | ― | Informative Buy | 96.46K | $79.50K | |
| CNXRConnecture Inc | Apr 27, 2018 | ― | Uninformative Sell | 47.91K | $0.00 | |
| SPRYARS Pharmaceuticals | ― | Director | ― | ― | ||
| ~~THORSynthorx | ― | ― | ― | ― |
You May Also Like
Vickie Capps insider profile FAQ
What is the percentage of profitable transactions made by Vickie Capps?
The percentage of profitable transactions made by Vickie Capps is 50%.
What is the average return per transaction made by Vickie Capps?
The average return per transaction made by Vickie Capps is -12.80%.
What stocks does Vickie Capps hold?
Vickie Capps holds: JANX, AMED, OFIX, OTIC, ~~THOR, SPRY, CNXR, NUVA stocks.
What was Vickie Capps's most profitable transaction?
Vickie Capps’s most profitable transaction was an Informative Buy of AMED stock on February 26, 2020. The return on the trade was 34.20%.
What is Vickie Capps's role in Janux Therapeutics Inc?
Vickie Capps's role in Janux Therapeutics Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.